# Clinical Study on Autologous Platelet-rich Plasma (PRP) Treatment for Refractory Benign Airway Stenosis

> **NCT03892837** · NA · UNKNOWN · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 24 (estimated)

## Conditions studied

- Benign Airway Stenosis

## Interventions

- **PROCEDURE:** PRP
- **PROCEDURE:** Conventional treatment for benign airway stenosis

## Key facts

- **NCT ID:** NCT03892837
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04
- **Primary completion:** 2020-09
- **Final completion:** 2021-04
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03892837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03892837, "Clinical Study on Autologous Platelet-rich Plasma (PRP) Treatment for Refractory Benign Airway Stenosis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03892837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*